RecruitingNCT05375617

European Prospective Investigation Into Childhood Cancer

Southern European Prospective Investigation Into Childhood Cancer and Nutrition (EPICkids)


Sponsor

Columbia University

Enrollment

1,400 participants

Start Date

Jul 7, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Over the last decades, research has shown that poor nutritional status can adversely impact prognosis and increase toxicities during treatment for childhood cancer. EPICkids is a collaboration between the International Initiative for Pediatrics and Nutrition, the International Agency for Research on Cancer, and sites throughout three Southern European countries (Spain, Greece, and Italy). The primary aim of EPICkids is to establish an informational resource on critical nutrition parameters wherein we can describe the trajectory of nutritional status among Southern European children and adolescents with acute lymphoblastic leukemia (ALL) and favorable biology brain tumors, investigate lifestyle behaviors, sociodemographic factors, and quality of life and correlate these indicators with clinical outcomes. The specimens obtained with the proposed study will foster future studies on nutrition and prevalent childhood cancer as well as establish a framework to develop evidence-based guidelines for European children with cancer, utilizing regional, European data. We plan to recruit 900 patients with ALL and 1400 patients with a favorable biology brain tumor over five years. Nutrition parameters and lifestyle factors will be measured at systematic timepoints over the study period. Stool and blood specimens will be collected at each timepoint. Eligible patients will be between 3 and 21 years of age.


Eligibility

Min Age: 3 YearsMax Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This is a European research study following children and young adults with leukemia (ALL) or certain brain tumors to understand how cancer and its treatment affect them over time, including long-term health and quality of life. **You may be eligible if...** - You are between 3 and 21 years old - You have been newly diagnosed with a type of leukemia (B-cell ALL, T-cell ALL, or mixed leukemia) confirmed by lab testing - OR you have been newly diagnosed with a low-risk brain tumor (such as low-grade glioma, medulloblastoma, or ependymoma) - You are receiving or will receive standard cancer treatment **You may NOT be eligible if...** - Your cancer does not match the specific types included - You are outside the age range Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObservational

No intervention


Locations(1)

Columbia University Irving Medical Center

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05375617


Related Trials